Get the Stockscreener App
0.7643
6.95%
0.0497
Pre-market:
.77
0.0057
+0.75%
China Pharma Holdings Inc. stock is traded at $0.7643, with a volume of 59,325.
It is up +6.95% in the last 24 hours and down -26.51% over the past month.
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, cephalosporin oral solutions, and granules. The company's products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Anhydroandrographolide for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; and Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. is headquartered in Haikou, the People's Republic of China.
See More
Previous Close:
$0.7146
Open:
$0.721
24h Volume:
59,325
Relative Volume:
0.22
Market Cap:
$30.97M
Revenue:
$3.99M
Net Income/Loss:
$-3.55M
P/E Ratio:
-1.3874
EPS:
-0.5509
Net Cash Flow:
$94,500
1W Performance:
+7.63%
1M Performance:
-26.51%
6M Performance:
-50.05%
1Y Performance:
-53.11%
1-Day Range:
$0.721
$0.8345
1-Week Range:
$0.71
$0.899
52-Week Range:
$0.3818
$2.05
China Pharma Holdings Inc. Stock (CPHI) Company Profile
Name
China Pharma Holdings Inc.
Sector
Phone
86 898 6681 1730
Address
No. 17, Jinpan Road, Second Floor, Haikou
Compare CPHI vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CPHI
China Pharma Holdings Inc.
|
0.7643 | 30.97M | 3.99M | -3.55M | 94,500 | -0.5509 |
TAK
Takeda Pharmaceutical Co Adr
|
15.77 | 49.83B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.07 | 40.04B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.69 | 39.23B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
79.95 | 33.52B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
549.57 | 23.33B | 3.17B | 1.29B | 1.01B | 27.09 |
China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-10 | Initiated | Rodman & Renshaw | Mkt Outperform |
China Pharma Holdings Inc. Stock (CPHI) Latest News
World Gel Matrix Transdermal SystemsMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
Chewy Reports Strong FQ1 2026 Results; Analysts Highlight Mid-Cap Growth PotentialProduct Revenue Analysis - newsline.com
AMC Q1 2026 Earnings: Narrower-Than-Expected Loss Boosts Investor SentimentGuidance Accuracy Score - newsline.com
Japanese Pharma Giants Look to China for Drug Discovery and Growth OpportunitiesEarnings Surprise Stocks - newsline.com
Shanghai Fosun Pharmaceutical Stock (CNE100000536): shares in focus amid quiet news flow - AD HOC NEWS
CPHI Q3 2011 Earnings: Significant EPS Miss Amid Challenging QuarterRevenue Report - newsline.com
CPHI Q3 2011 Earnings: EPS Misses Estimates Amid Challenging QuarterEarnings Trend Analysis - newsline.com
OGE Energy Slips 2.9%: Defensive Utility Faces Technical HeadwindsBreakout Confirmation - newsline.com
CPHI Q3 2011 Earnings: EPS Misses Estimates Significantly, Stock DeclinesMargin Improvement Report - newsline.com
Arrowhead Pharmaceuticals Q1 2026 Earnings: EPS Surprise on Lower Expenses Offsets Revenue VoidDividend Increase Stocks - newsline.com
Marvell Technology and Flex Set to Join S&P 500, Replacing Pool and Campbell’sPost-Announcement Reaction - newsline.com
CPHI Q3 2011 Earnings: EPS Misses Estimates, Stock Declines 12.9%Earnings Volatility Report - newsline.com
May Jobs Report Expected to Show Slower Hiring: Reality Check for Strong StartGross Profit Margin - newsline.com
The Pharma Choke Point - Council on Foreign Relations
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
CPHI Q3 2011 Earnings: EPS Misses Estimates Despite Strong Stock RallyEarnings Beat Alert - newsline.com
China Pharma Holdings (CPHI) Holds Steady at $0.79 as Key Support and Resistance Levels Remain in FocusProfitability Factor - The Legal Advocate
China NT Pharma Group Announces Proposed Disposal of NT Pharma (Overseas) Holding Co., Ltd Equity Interests to Alleviate Liquidity Strain 12 - Minichart
KOP Q1 2026 Earnings: EPS Surprises by Nearly 30% Amid Revenue Silence, Stock SlipsEstimate Uncertainty - The Legal Advocate
symbol__ Stock Quote Price and Forecast - CNN
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Udemy Inc. (UDMY) Stabilizes Near Support as Market Awaits CatalystChandelier Stop - The Legal Advocate
China Pharma Company Profile & Introduction - Moomoo
China pharma industry not impacted by Beijing scrutiny of sensitive tech deals, JW chief says - Yahoo Finance
China Pharma Holdings (CPHI) Hovers Near Support as Micro-Cap Stock Holds Slim GainsStock News - newsline.com
China Pharma Holdings (CPHI) Q3 2011 Earnings: EPS Miss Weighs on SentimentEPS Guidance Update - newsline.com
CPHI Q3 2011 Earnings: EPS Falls Short of Consensus Amid Operational HeadwindsPerformance Review - newsline.com
Rafael Holdings (RFL) Sees Modest Uptick, Testing Key Resistance at $1.41MA Cross Alert - The Legal Advocate
CPHI Stock Chart | CHINA PHARMA HOLDINGS INC (NYSEARCA:CPHI) - ChartMill
12 Health Care Stocks Moving In Monday's Intraday Session - Sahm
Trump's China Visit: US CEOs Musk, Cook and Nvidia’s Huang Join Trade TalksEarnings Forecast Report - newsline.com
China Pharma Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
South Korea’s Reversal on AI Tax Proposal Seen as Positive Signal for Micron (MU) StockShare Dilution Risk - newsline.com
China Pharma Holdings, Inc. States It Knows of No Events That Could Have Caused Unusual Market Activity - digitalmore.co
China Pharma says unaware of reason for unusual trading - Investing.com
China Pharma says unaware of reason for unusual trading By Investing.com - Investing.com Nigeria
China Pharma Holdings IncNYSE American contacts China Pharma regarding unusual market activity on May 12 and 13 - marketscreener.com
Unusual volume stocks are being observed in Wednesday's session. - ChartMill
TradingKey - TradingKey
These stocks are moving in today's after hours session - ChartMill
C3 AI Announces Q4 and Fiscal Year 2026 Preliminary Results: Tom Siebel Returns as CEO, Reports Revenue Within Guidance and Improved Operating Losses - Minichart
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
US Stock Market Trends: Updated Data Analysis & Real-Time Quotes - TradingKey
Why Eastern International (ELOG) earnings always move the needle |Earnings Trend Analysis - newsline.com
CPHI PE Ratio & Valuation, Is CPHI Overvalued - Intellectia AI
China NT Pharma Group Quarterly Update on Action Plans for Disclaimer of Opinion Resolution and AI Health Business Transformation 1 - Minichart
Chinese firm Livzon secures control of Vietnam’s pharma giant Imexpharm in $228 mln deal - Theinvestor
Why Seagate Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Benzinga
Top LosersStock ScreenerSnapshot - Finviz
CPHI Technical Analysis & ETF Price Forecast - Intellectia AI
EBITDA per share of China Pharma Holdings, Inc. – AMEX:CPHI - TradingView
China Pharma Holdings Inc. Stock (CPHI) Financials Data
Revenue
Net Income
Cash Flow
EPS
9.24%
0.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):